Cambrooke Therapeutics

Cambrooke Therapeutics

Signal active

Organization

Contact Information

Overview

we dedicated exclusively to providing innovative clinical nutrition products. Our products are administered under medical supervision and are intended for patients who require specialized dietary therapies. We are committed to changing the way people, who require clinical nutrition, experience their diet.

About

Industries

Biotechnology, Health Care, Pharmaceutical, Fitness, Therapeutics, Nutrition

Founded

2000

Employees

101-250

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Cambrooke Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Fitness, Therapeutics, Nutrition sector. The company focuses on Biotechnology and has secured $739.8M in funding across 72 round(s). With a team of 101-250 employees, Cambrooke Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Cambrooke Therapeutics, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Lynn Paolella

Lynn Paolella

co-founder

Funding Rounds

Funding rounds

3

Investors

0

Lead Investors

0

Total Funding Amount

$10.3M

Details

1

Cambrooke Therapeutics has raised a total of $10.3M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2016Late Stage Venture

Investors

Cambrooke Therapeutics is funded by 5 investors.

Investor NameLead InvestorFunding RoundPartners
Seventure Partners-FUNDING ROUND - Seventure Partnersundefined
Galen Partners-FUNDING ROUND - Galen Partnersundefined
Cambrooke Therapeutics-FUNDING ROUND - Cambrooke Therapeuticsundefined
Ruffena Capital-FUNDING ROUND - Ruffena Capitalundefined

Recent Activity

There is no recent news or activity for this profile.